NCT03198195View on ClinicalTrials.gov

Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

UnknownOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

March 10, 2015

Primary Completion Date

March 10, 2017

Study Completion Date

July 10, 2020

Conditions
Wiskott-Aldrich Syndrome
Interventions
PROCEDURE

cyclophosphamide

on days +3，+4,using cyclophosphamide 50mg/kg

Sponsors
All Listed Sponsors
lead

Capital Research Institute of Pediatrics

OTHER_GOV